Page last updated: 2024-12-08

mrs 1191

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

MRS 1191: a selective A3 adenosine receptor antagonist; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID393594
CHEMBL ID89852
CHEMBL ID1995014
CHEBI ID175753
SCHEMBL ID3741774
MeSH IDM0280150

Synonyms (31)

Synonym
CHEMBL89852 ,
CHEBI:175753
furcelleran
5-o-benzyl 3-o-ethyl 2-methyl-6-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate
gtpl470
o3-ethyl o5-(phenylmethyl) 2-methyl-6-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate
NCI60_034240
mrs1191
mrs 1191, solid
nsc-695673
nsc695673
mrs 1191
mrs-1191
L000412
185222-90-6
SCHEMBL3741774
CHEMBL1995014
FT-0699601
DTXSID10327856
3-benzyl 5-ethyl 6-methyl-2-phenyl-4-(2-phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate
danish agar
burtonitte 44
J-011875
CS-0086877
HY-124543
Q27087758
AS-16486
3-benzyl 5-ethyl 6-methyl-2-phenyl-4-(phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate
3-benzyl5-ethyl6-methyl-2-phenyl-4-(phenylethynyl)-1,4-dihydropyridine-3,5-dicarboxylate
AKOS037643454
3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(+/-)-dihydropyridine-3,5-dicarboxylate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cinnamate ester
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Purinergic signaling053

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Adenosine receptor A3Homo sapiens (human)Ki0.02130.00000.930610.0000AID34125; AID34710; AID34862; AID34872
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki30.08500.00011.20929.9700AID32174; AID32336; AID32341
Adenosine receptor A3Rattus norvegicus (Norway rat)Ki1.42000.00030.91969.0000AID33355; AID33481
Adenosine receptor A2aRattus norvegicus (Norway rat)Ki0.10000.00021.494010.0000AID32871
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
inflammatory responseAdenosine receptor A3Homo sapiens (human)
signal transductionAdenosine receptor A3Homo sapiens (human)
activation of adenylate cyclase activityAdenosine receptor A3Homo sapiens (human)
regulation of heart contractionAdenosine receptor A3Homo sapiens (human)
negative regulation of cell population proliferationAdenosine receptor A3Homo sapiens (human)
response to woundingAdenosine receptor A3Homo sapiens (human)
regulation of norepinephrine secretionAdenosine receptor A3Homo sapiens (human)
negative regulation of cell migrationAdenosine receptor A3Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityAdenosine receptor A3Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionAdenosine receptor A3Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A3Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
G protein-coupled adenosine receptor activityAdenosine receptor A3Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
plasma membraneAdenosine receptor A3Homo sapiens (human)
presynaptic membraneAdenosine receptor A3Homo sapiens (human)
Schaffer collateral - CA1 synapseAdenosine receptor A3Homo sapiens (human)
dendriteAdenosine receptor A3Homo sapiens (human)
plasma membraneAdenosine receptor A3Homo sapiens (human)
synapseAdenosine receptor A3Homo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (26)

Assay IDTitleYearJournalArticle
AID1345822Human A3 receptor (Adenosine receptors)1997Neuropharmacology, Sep, Volume: 36, Issue:9
Pharmacological characterization of novel A3 adenosine receptor-selective antagonists.
AID1345831Rat A3 receptor (Adenosine receptors)1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
AID1345822Human A3 receptor (Adenosine receptors)1996Journal of medicinal chemistry, Nov-08, Volume: 39, Issue:23
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
AID31551Binding affinity towards adenosine A1 receptor by measuring its ability to displace [3H]-R-PIA in rat brain membranes at a concentration of 10e-4 M1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
AID232043Selectivity for binding affinity towards A1 adenosine receptor in rat brain membrane and human A3 receptor expressed in HEK cells1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
AID33068Binding affinity towards adenosine A3 receptor by measuring its ability to displace [125I]AB-MECA binding to membranes prepared from HEK293 cells1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
AID32018Binding affinity against adenosine A1 receptor in rat cerebral cortex membrane by radioligand binding assay using [3H](R)-PIA.1996Journal of medicinal chemistry, Nov-08, Volume: 39, Issue:23
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
AID34710Binding affinity at cloned human adenosine A3 receptor expressed in HEK293 cells was determined using [125I]AB-MECA as radioligand1998Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
AID32336Displacement of [3H]-R-PIA from adenosine A1 receptor of rat brain membrane1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.
AID34125Inhibition of [125I]- AB-MECA binding to human Adenosine A3 receptors expressed in HEK cells1996Journal of medicinal chemistry, Nov-08, Volume: 39, Issue:23
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
AID33355Displacement of specific [125I]AB-MECA binding at rat Adenosine A3 receptor in CHO cells1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
AID35004Displacement of [3H]CGS-21680 from Adenosine A2A receptor of rat striatal membrane at 10e-4 uM1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.
AID32174Binding affinity was determined in radioligand binding assay at rat brain adenosine A1 receptor vs [3H]R-PIA1998Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
AID34872Displacement of specific [125I]AB-MECA binding at human adenosine A3 receptor.1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
AID32341Displacement of specific [3H](R)-PIA binding at adenosine A1 receptor from rat brain membranes.1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
AID34862Displacement of [125 I]AB-MECA from Adenosine A3 receptor expressed in HEK cells1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.
AID32644Relative binding to rat adenosine A1 and human adenosine A3 receptors1999Journal of medicinal chemistry, Aug-12, Volume: 42, Issue:16
Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.
AID233441Selectivity ratio measured as the Ki value of rat A1 receptor to that of hA3 receptor.1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
AID232971Relative affinities for rat adenosine A1 and human adenosine A3 receptors1996Journal of medicinal chemistry, Nov-08, Volume: 39, Issue:23
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
AID34988Displacement of specific [3H]-CGS- 21680 binding at Adenosine A2A receptor in rat striatal membranes at the concentration of 10e-4 M1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
AID33947Binding affinity for Adenosine A2A receptor in rat striatal membrane with [3H]-CGS- 216801996Journal of medicinal chemistry, Nov-08, Volume: 39, Issue:23
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists.
AID32871Binding affinity was determined in radioligand binding assay at rat striatal Adenosine A2A receptor vs [3H]-CGS- 216801998Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes.
AID33495Binding affinity towards adenosine A3 receptor by [125I]AB-MECA displacement.1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
AID33035Binding affinity towards adenosine A2A receptor by measuring its ability to displace [3H]-CGS- 21680 in rat striatal membranes at a concentration of 10e-4 M1998Journal of medicinal chemistry, Aug-13, Volume: 41, Issue:17
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
AID33481Displacement of specific [125I]AB-MECA binding at rat Adenosine A3 receptor stably expressed in CHO cells1999Journal of medicinal chemistry, Feb-25, Volume: 42, Issue:4
Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.
AID233439Selectivity ratio measured as the Ki ratio of rat A1 receptor to that of rat A3 receptor.1997Journal of medicinal chemistry, Aug-01, Volume: 40, Issue:16
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (42)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's11 (26.19)18.2507
2000's25 (59.52)29.6817
2010's6 (14.29)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.63 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other43 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]